Tinnitus Evaluation Program Offers Treatment Measure Outcomes

By David W. Holmes, PhD MelMedtronics will release its new Tinnitus Evaluation Program (TEP) software in October. This product is Medicare-compliant and reimbursable, creating opportunity for an untapped revenue stream in audiology and otolaryngology practices. Medicare approved a new CPT code for tinnitus evaluation (CPT-92625) seven years ago, and four evaluation requirements comply with the procedure. Frequency match, intensity match, minimum masking level, and presence of residual inhibition must be documented for patients’ tinnitus measurements. Medicare currently reimburses an average of $67.44 (depending on geographical area) for CPT-92625, with a diagnosis of subjective tinnitus (ICD-9, 388.31). No modifier is required. Fifty percent of patients in a typical audiology practice present with tinnitus, and the incidence is approximately 70 percent in an otolaryngology practice. Patients have long complained about providers telling them they would have to learn to live with their tinnitus, but this should no longer apply. MelMedtronics’ TEP provides an efficient method of evaluating tinnitus with a variety of treatments available.   TEP Breakdown Providers who register at www.melmedtronics.com can download the TEP software. The program generates revenue, is Medicare compliant, takes seven to 10 minutes to complete, and requires no capital outlay, monthly fee, or special equipment. It is also easy to administer, and is compatible with all platforms. TEP generates a c...
Source: R&D Blog - Category: ENT & OMF Tags: Blog Posts Source Type: blogs